ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2022
PORTLAND, Maine, Feb. 15, 2023 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the year ended December 31, 2022 after the market closes on Tuesday, February 21, 2023.
Related news for (ICCC)
- ImmuCell Embarks on CEO Succession Planning Process
- ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
- ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025
- ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025
- ImmuCell Hires Chief Financial Officer